The SmartTRAK team will be attending the upcoming International Society for the Advancement of Spine Surgery (ISASS) in The Bahamas and we would love to schedule some time to meet. We are particularly excited about this year’s conference program and speakers.

Our team of expert analysts have their finger on the pulse on the spine industry trends, news, financial data and competitor developments. We would like to meet to hear your perspectives and views and discuss how SmartTRAK can help you make more informed strategic business decisions.

Watch the video below to meet Courtney Sheedy, SmartTRAK's GM, Spine

Build an Enterprise of Experts, so your
Company can build the next big thing.

From economics to the ASC shift, SmartTRAK looks at the trends affecting the Total Joints Market

The start of the new year did not play out as so many of us had hoped. Heading into 2022, the next COVID surge reared its ugly head with the Omicron variant storming through countries around the globe. Healthcare facilities once again postponed elective procedures due to capacity issues and/or staff or patients being diagnosed with COVID. Overall inflation rose to a level that hasn’t been seen since the early 1980s. Looking ahead, is there a silver lining in this dark cloud? SmartTRAK believes the forecast is not all doom and gloom. Let’s look at some of the trends affecting the climate of the Total Joints market.

(Continue reading to find out how to receive FREE SmartTRAK DAILY UPDATES)

In an interview with SmartTRAK, University of Arizona professor Dr. Philipp Gutruf discusses research on a new class of bioelectronics he calls osseosurface electronics and its application in the orthopedic field. Dr. Gutruf is an Assistant Professor in the Biomedical Engineering Department at the University of Arizona and his research group focuses on creating devices that integrate with biological systems by combining innovations in soft materials, photonics and electronics to create systems with broad impact on health diagnostics, therapeutics and exploratory neuroscience. 

Jason Winkler, Sales VP of cybersecurity startup Device Authority, discusses the state of cybersecurity in healthcare in an interview with SmartTRAK.

In an interview with SmartTRAK, Device Authority VP of Sales (Americas) Jason Winkler discusses the state of cybersecurity in healthcare and medical devices.

To find out more, including the devices most vulnerable to cybersecurity threats and how medical device manufacturers should think about designing cybersecurity measures into their connected products, click on the following video to listen to the full interview (17:29 min). A link to download the complete transcript of the interview is also provided below.

Erez Lampert, CEO and Founder of Israeli start-up Pathkeeper Surgical, discusses the Company’s real-time spinal navigation system that’s generating high interest from ASCs in an interview with SmartTRAK 

In an interview with SmartTRAK, Pathkeeper Surgical CEO and Founder Erez Lampert discusses Pathkeeper’s mobile, light-weight spinal navigation system. 

To find out more, including the timeline for FDA approval and demand from surgeons, hospitals and ASCs, click on the following video to listen to the full interview (22:29 min). A link to download the complete transcript of the interview is also provided below.

Dr. Mark Figgie, Hospital for Special Surgery, and Nick Deeter, Founder & CEO WishBone Medical discuss their journey to develop a pediatric-specific hip replacement system in an interview with SmartTRAK

Dr. Mark P. Figgie, Chief of Surgical Arthritis Service at Hospital for Special Surgery (HSS) in New York City, and Nick Deeter, Founder and CEO of WishBone Medical discuss their collaboration on the development of the first off-the-shelf hip replacement system for pediatric patients in an interview with   SmartTRAK. Dr. Figgie shares how his 30-year experience with complex joint replacements, many in juvenile patients, led to his collaboration with WishBone medical to create a hip system specifically tailored for pediatric and young adult patients.

To find out more, including the indications for a pediatric hip replacement, the global market implications, and the next steps Dr. Figgie and WishBone will be taking to bring this hip system to the market, click on the video below to listen to the recorded interview (17:53 min). A link to download the complete transcript of the interview is also provided below.

New products and signs of procedural recovery lighten the mood at AAOS 2022

The mood at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting was upbeat despite scaled-back attendance and exhibit space. Surgeons and exhibitors alike were excited to get back to in-person discussions about issues in orthopedics, new products hitting the market and the potential for recovery from the impact of COVID. While at the meeting, SmartTRAK met with industry professionals from clinicians to company representatives identifying key takeaways from market drivers and limiters to new product introductions.

(Continue reading to find out how to receive FREE SmartTRAK DAILY UPDATES)

New Products:

• Cardinal Health* 
  

  Cardinal Health announced the launch of the first surgical incise drape using Chlorhexidine Gluconate (CHG). The drape features Avery Dennison's patented BeneHold CHG adhesive technology, which helps reduce the risk of surgical site contamination w/ organisms associated w/ SSIs.

• Coloplast*

  Coloplast is gradually launching Alprep Pad in select markets. Now available in the UK, Australia and New Zeeland. Alprep Pad is a foam for mechanical cleansing and debridement of wounds.

New product introductions offset slightly weaker Q4 results due to COVID-19 headwinds and international pressure.

While the Trauma segment was not impacted as heavily due to COVID-19 headwinds, companies that play within the space were impacted by deferrals of elective surgeries such as limb restoration. Long bone trauma volumes remained healthy as players cited new product introductions as growth drivers for the segment. 

Among the many topics covered in detail in our comprehensive Q421/FY21 Trauma Market Recap* are:

Scott Laster, CEO and co-founder of MiCare Path, discusses the present and future of monitoring patients between office visits in an interview with SmartTRAK

Scott Laster is the CEO and co-founder of MiCare Path, a leading platform to connect patients with their providers between visits. Scott is a medical device industry veteran with 15+ years of experience in the trenches launching products and supporting clinicians. In this interview with SmartTRAK, Scott shares his thoughts on the benefits of monitoring patients between office visits, the evolution of reimbursement of remote monitoring and where MiCare Path is going in the future.

To find out more, including Scott’s take on how MiCare Path benefits orthopedic and wound care patients and clinicians, click on the following video recorded live via Google Meet (17:04 min). Specific interview topics by timecode are outlined below. To download a complete transcript of the interview, click here.